Compare Dicks Sporting Goods Inc (DKS) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dicks Sporting Goods Inc vs Recursion Pharmaceuticals Inc — how do they compare? Dicks Sporting Goods Inc trades at $206.29 (market cap $18.35B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Dicks Sporting Goods Inc is far larger — about 10.1× Recursion Pharmaceuticals Inc's market cap, and Dicks Sporting Goods Inc pays a 2.44% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| DKS | RXRX | |
|---|---|---|
Market Cap | $18.35B | $1.81B |
Sector | Consumer Cyclical | Health |
52-Week High | $239.17 | $6.79 |
52-Week Low | $187.78 | $2.84 |
Enterprise Value | $25.14B | $1.33B |
Dividend Yield | 2.44% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dicks Sporting Goods Inc
Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
